SOURCE-LINKED INTELLIGENCE
Harnessing biobanking, Organ models, and Patient Empowerment for a better quality of life for women living within Polyendocrine Metabolic Ovary Syndrome
4PMOS brings together a multidisciplinary consortium: two leading university hospitals specializing in PMOS, one academic public health expert, two academic partners renowned for 3D organ modeling, a machine learning expert, two biotech and digital health SMEs, a pharma service provider with expertise in women’s health, and a women’s health patient organization. Through cutting-edge science, patient-centered innovation and a strategic exploitation strategy, hope4PMOS will significantly advance women’s health research, accelerate personalized medicine and contribute to the EU’s goals of equity, innovation and global leadership in biomedical research. Polyendocrine Metabolic Ovary Syndrome, women's health, patient empowerment, (digital) biomarkers, organoids, Organ-on-Chip, therapeutic discovery, multimorbidities
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 5994224.75
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T05:31:32.981Z. This is not the publication date.